Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Revvity Health Sciences Inc Revvity Cas9-gRNA Globin Depletion Enzyme, Human, HBA1, HBA2, HBB, HBD Targeting
Supplier: Revvity Health Sciences Inc NOVA802500
This standalone, flexible CRISPR-Cas9 module is designed to remove globin-derived sequences from human blood RNA-seq libraries. It can be integrated into existing bulk or single-cell RNA-seq workflows at the double-stranded DNA stage, which reduces hemoglobin background and improves transcriptome coverage by directing reads toward informative transcripts.
- Standalone, flexible CRISPR-Cas9 module
- Removes globin-derived sequences from human blood RNA-seq libraries
- Integrates into existing bulk or single-cell RNA-seq workflows at the double-stranded DNA stage
- Reduces hemoglobin background for improved transcriptome coverage
- Supplied as a pre-complexed Cas9-guide RNA mixture
- Contains 30 guide RNAs targeting HBA1, HBA2, HBB, and HBD loci
- Highly cost-competitive and widely compatible
- Enables efficient globin depletion without requiring a specific library prep kit
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?